compounding semaglutide enforcement news The FDA is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA Ozempic copies restricted after US

In this sense, progesterone's role in supporting sleep is not merely a quality-of-life consideration

Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation

Statements Author contributions EK: Writing review & editing, Writing original draft, Project administration, Funding acquisition, Formal analysis

The potential applications and challenges of targeted metabolic reprogramming in the cardioprotective effects of GLP-1RAs are further discussed

Significant weight loss such as that observed in retatrutide trials can have meaningful effects on the endocrine system, including changes to oestrogen levels, menstrual cycle regularity, and fertility

Its simpler than it sounds